MedEquities Realty Trust (NYSE:MRT) has been assigned a consensus rating of “Hold” from the eight analysts that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $12.40.
Several research firms recently issued reports on MRT. B. Riley set a $13.00 target price on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a research report on Monday. JMP Securities set a $13.00 target price on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a research report on Friday, May 11th. ValuEngine cut shares of MedEquities Realty Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Citigroup decreased their target price on shares of MedEquities Realty Trust from $12.00 to $10.00 and set a “neutral” rating on the stock in a research report on Thursday, March 1st. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $14.00 target price on shares of MedEquities Realty Trust in a research report on Wednesday, February 21st.
In related news, Director Bluemountain Capital Managemen sold 18,346 shares of the firm’s stock in a transaction that occurred on Wednesday, May 16th. The shares were sold at an average price of $10.32, for a total value of $189,330.72. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders sold 235,786 shares of company stock worth $2,435,627 over the last three months. Corporate insiders own 2.50% of the company’s stock.
Shares of MedEquities Realty Trust traded up $0.07, hitting $10.39, during mid-day trading on Thursday, Marketbeat Ratings reports. 126,255 shares of the stock were exchanged, compared to its average volume of 156,942. MedEquities Realty Trust has a twelve month low of $10.27 and a twelve month high of $10.43. The stock has a market capitalization of $326.84 million, a P/E ratio of 9.11 and a beta of -0.18.
MedEquities Realty Trust (NYSE:MRT) last released its earnings results on Thursday, May 10th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.30 by ($0.14). MedEquities Realty Trust had a return on equity of 6.17% and a net margin of 34.63%. The company had revenue of $16.72 million during the quarter, compared to analyst estimates of $16.41 million. equities research analysts predict that MedEquities Realty Trust will post 1.2 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 5th. Investors of record on Tuesday, May 22nd will be given a $0.21 dividend. The ex-dividend date of this dividend is Monday, May 21st. This represents a $0.84 annualized dividend and a dividend yield of 8.08%. MedEquities Realty Trust’s dividend payout ratio is presently 73.68%.
About MedEquities Realty Trust
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.